Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery

Shinji Kuroda, Toshiya Fujiwara, Yasuhiro Shirakawa, Yasumoto Yamasaki, Shuuya Yano, Futoshi Uno, Hiroshi Tazawa, Yuuri Hashimoto, Yuichi Watanabe, Kazuhiro Noma, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The inability to repair DNA double-strand breaks (DSB) leads to radiosensitization, such that ionizing radiation combined with molecular inhibition of cellular DSB processing may greatly affect treatment of human cancer. As a variety of viral products interact with the DNA repair machinery, oncolytic virotherapy may improve the therapeutic window of conventional radiotherapy. Here, we describe the mechanistic basis for synergy of irradiation and OBP-301 (Telomelysin), an attenuated type-5 adenovirus with oncolytic potency that contains the human telomerase reverse transcriptase promoter to regulate viral replication. OBP-301 infection led to E1B55kDa viral protein expression that degraded the complex formed by Mre11, Rad50, and NBS1, which senses DSBs. Subsequently, the phosphorylation of cellular ataxia-telangiectasia mutated protein was inhibited, disrupting the signaling pathway controlling DNA repair. Thus, tumor cells infected with OBP-301 could be rendered sensitive to ionizing radiation. Moreover, by using noninvasive whole-body imaging, we showed that intratumoral injection of OBP-301 followed by regional irradiation induces a substantial antitumor effect, resulting from tumor cell-specific radiosensitization, in an orthotopic human esophageal cancer xenograft model. These results illustrate the potential of combining oncolytic virotherapy and ionizing radiation as a promising strategy in the management of human cancer.

Original languageEnglish
Pages (from-to)9339-9348
Number of pages10
JournalCancer Research
Volume70
Issue number22
DOIs
Publication statusPublished - Nov 15 2010

Fingerprint

Human Adenoviruses
Telomerase
Ionizing Radiation
DNA Repair
Oncolytic Virotherapy
Neoplasms
Ataxia Telangiectasia Mutated Proteins
Whole Body Imaging
Double-Stranded DNA Breaks
Viral Proteins
Esophageal Neoplasms
Heterografts
Adenoviridae
Radiotherapy
Phosphorylation
Injections
Therapeutics
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery. / Kuroda, Shinji; Fujiwara, Toshiya; Shirakawa, Yasuhiro; Yamasaki, Yasumoto; Yano, Shuuya; Uno, Futoshi; Tazawa, Hiroshi; Hashimoto, Yuuri; Watanabe, Yuichi; Noma, Kazuhiro; Urata, Yasuo; Kagawa, Shunsuke; Fujiwara, Toshiyoshi.

In: Cancer Research, Vol. 70, No. 22, 15.11.2010, p. 9339-9348.

Research output: Contribution to journalArticle

@article{0b59101eafe145db9d9d7f3462d6a727,
title = "Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery",
abstract = "The inability to repair DNA double-strand breaks (DSB) leads to radiosensitization, such that ionizing radiation combined with molecular inhibition of cellular DSB processing may greatly affect treatment of human cancer. As a variety of viral products interact with the DNA repair machinery, oncolytic virotherapy may improve the therapeutic window of conventional radiotherapy. Here, we describe the mechanistic basis for synergy of irradiation and OBP-301 (Telomelysin), an attenuated type-5 adenovirus with oncolytic potency that contains the human telomerase reverse transcriptase promoter to regulate viral replication. OBP-301 infection led to E1B55kDa viral protein expression that degraded the complex formed by Mre11, Rad50, and NBS1, which senses DSBs. Subsequently, the phosphorylation of cellular ataxia-telangiectasia mutated protein was inhibited, disrupting the signaling pathway controlling DNA repair. Thus, tumor cells infected with OBP-301 could be rendered sensitive to ionizing radiation. Moreover, by using noninvasive whole-body imaging, we showed that intratumoral injection of OBP-301 followed by regional irradiation induces a substantial antitumor effect, resulting from tumor cell-specific radiosensitization, in an orthotopic human esophageal cancer xenograft model. These results illustrate the potential of combining oncolytic virotherapy and ionizing radiation as a promising strategy in the management of human cancer.",
author = "Shinji Kuroda and Toshiya Fujiwara and Yasuhiro Shirakawa and Yasumoto Yamasaki and Shuuya Yano and Futoshi Uno and Hiroshi Tazawa and Yuuri Hashimoto and Yuichi Watanabe and Kazuhiro Noma and Yasuo Urata and Shunsuke Kagawa and Toshiyoshi Fujiwara",
year = "2010",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-10-2333",
language = "English",
volume = "70",
pages = "9339--9348",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery

AU - Kuroda, Shinji

AU - Fujiwara, Toshiya

AU - Shirakawa, Yasuhiro

AU - Yamasaki, Yasumoto

AU - Yano, Shuuya

AU - Uno, Futoshi

AU - Tazawa, Hiroshi

AU - Hashimoto, Yuuri

AU - Watanabe, Yuichi

AU - Noma, Kazuhiro

AU - Urata, Yasuo

AU - Kagawa, Shunsuke

AU - Fujiwara, Toshiyoshi

PY - 2010/11/15

Y1 - 2010/11/15

N2 - The inability to repair DNA double-strand breaks (DSB) leads to radiosensitization, such that ionizing radiation combined with molecular inhibition of cellular DSB processing may greatly affect treatment of human cancer. As a variety of viral products interact with the DNA repair machinery, oncolytic virotherapy may improve the therapeutic window of conventional radiotherapy. Here, we describe the mechanistic basis for synergy of irradiation and OBP-301 (Telomelysin), an attenuated type-5 adenovirus with oncolytic potency that contains the human telomerase reverse transcriptase promoter to regulate viral replication. OBP-301 infection led to E1B55kDa viral protein expression that degraded the complex formed by Mre11, Rad50, and NBS1, which senses DSBs. Subsequently, the phosphorylation of cellular ataxia-telangiectasia mutated protein was inhibited, disrupting the signaling pathway controlling DNA repair. Thus, tumor cells infected with OBP-301 could be rendered sensitive to ionizing radiation. Moreover, by using noninvasive whole-body imaging, we showed that intratumoral injection of OBP-301 followed by regional irradiation induces a substantial antitumor effect, resulting from tumor cell-specific radiosensitization, in an orthotopic human esophageal cancer xenograft model. These results illustrate the potential of combining oncolytic virotherapy and ionizing radiation as a promising strategy in the management of human cancer.

AB - The inability to repair DNA double-strand breaks (DSB) leads to radiosensitization, such that ionizing radiation combined with molecular inhibition of cellular DSB processing may greatly affect treatment of human cancer. As a variety of viral products interact with the DNA repair machinery, oncolytic virotherapy may improve the therapeutic window of conventional radiotherapy. Here, we describe the mechanistic basis for synergy of irradiation and OBP-301 (Telomelysin), an attenuated type-5 adenovirus with oncolytic potency that contains the human telomerase reverse transcriptase promoter to regulate viral replication. OBP-301 infection led to E1B55kDa viral protein expression that degraded the complex formed by Mre11, Rad50, and NBS1, which senses DSBs. Subsequently, the phosphorylation of cellular ataxia-telangiectasia mutated protein was inhibited, disrupting the signaling pathway controlling DNA repair. Thus, tumor cells infected with OBP-301 could be rendered sensitive to ionizing radiation. Moreover, by using noninvasive whole-body imaging, we showed that intratumoral injection of OBP-301 followed by regional irradiation induces a substantial antitumor effect, resulting from tumor cell-specific radiosensitization, in an orthotopic human esophageal cancer xenograft model. These results illustrate the potential of combining oncolytic virotherapy and ionizing radiation as a promising strategy in the management of human cancer.

UR - http://www.scopus.com/inward/record.url?scp=78549274429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549274429&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-2333

DO - 10.1158/0008-5472.CAN-10-2333

M3 - Article

C2 - 21045143

AN - SCOPUS:78549274429

VL - 70

SP - 9339

EP - 9348

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 22

ER -